Get full access to one story every week, and to summaries of all other stories. Just create a free account

It’s a jigsaw puzzle in your hip. That’s how Deepak Shivaratre describes 3D printed hip implants. The chief of orthopaedic oncology at Bengaluru-based HOSMAT Joint Replacement Centre, Shivaratre knows a thing or two about 3D printed implants, having done 10 hip replacement surgeries—all of them involving 3D printed hip implants.

Shivaratre’s tryst with 3D printed implants began back in 2008, during an almost 15-year-long stint with the Royal Liverpool University Hospital (RLUH) in the United Kingdom. Here, he had a ringside seat as 3D printed medical implants rose to prominence. 

MedGadget says the market for 3D printed medical implants worldwide was worth almost $1,125 million in 2018, and growing at close to 19% year-on-year.

Indeed, it is the potential of 3D printed implants that drew Shivaratre back to India—he wanted to be at the forefront of India’s nascent 3D printed medical devices space. Having designed implants for patients with tumours, he thought it was the future of orthopaedics and came back to India to see if the technology could be used similarly here.

“One of the reasons for me to relocate to India was to do 3D printing in India, I did not want to startup in Britain,” he explains. In addition to his role as a doctor, Shivaratre also serves as medical advisor to Singapore-based Supercraft3D Wellness.

“We take the CT scan and plan the implant such that it sits in the hip defect. It’s like a jigsaw puzzle”

Dr Deepak Shivaratre, Orthopaedic Oncologist, HOSMAT Joint Replacement Centre


With an office in Bengaluru, Supercraft3D is one of the companies leading the charge when it comes to 3D printed implants. Supercraft3D is hoping to make 3D printing as popular in the surgical space as it is in other medical areas like prosthetics, hearing aids, and dentistry. In dentistry, 3D printed products account for around 90% of the market, according to Raja Sekhara Upputuri, a founder of think3D, another startup that also makes 3D printed implants.

Sector agnostic technology

The industry is sector agnostic and can be used in any field—40% of think3D’s operations are focused on medical devices prototyping, while prosthetics, low volume manufacturing of components for defence and automotive sectors constitute 10% each, and prototyping for other sectors constitutes the rest of its operations


Last year alone, 300,000 3D printed hip implants have been printed in the US and Europe combined. China alone printed 60,000 implants,” says Supercraft’s CEO Maltesh Somasekharappa, illustrating the sector’s potential.

The Indian surgical space, however, has been a hard nut to crack.

AUTHOR

Suraksha P

Suraksha writes on Healthcare and Pharma. She has been a journalist for five years, reporting for The New Indian Express in Bengaluru and Chennai, and The Times of India, Delhi. In her previous stints she has written on health, civic issues and education. She investigated cover up of corruption in the state health department’s think tank, narrated harrowing tales of women who underwent unwarranted hysterectomies, and wrote about how loss of biometrics came in the way of Leprosy patients getting an Aadhaar card and thereby pension. She can be reached at suraksha at the-ken dot com.

View Full Profile

Subscribe to read this story

The Ken is the only business subscription you need. Questions?

 

Premium

  • 5 original and reported longform business stories every week
  • Access to ONLY India edition
  • Close to 250 exclusive stories every year
  • Full access to over 6 years of paywalled stories
  • Pick up to 5 premium subscriber newsletters
  • 4 original and reported longform business stories each week
  • Access to ONLY Southeast Asia edition
  • Close to 200 exclusive stories every year
  • Full access to all paywalled stories since March 2020
  • Pick up to 5 premium subscriber newsletters

Rs. 2,750 /year

$ 120 /year

India Edition
Subscribe Subscribe
Most Asked For

Borderless

  • 8 original and reported longform business stories each week
  • Access to both India and Southeast Asia editions
  • Close to 400 exclusive stories every year
  • Full access to over 6 years of paywalled stories across India and Southeast Asia
  • Unlimited access to all premium subscriber newsletters
  • Visual Stories

Rs. 4,200 /year

Subscribe
 

Echelon

  • 8 original and reported longform business stories each week
  • Access to both India and Southeast Asia editions
  • Close to 400 exclusive stories every year
  • Full access to over 6 years of paywalled stories across India and Southeast Asia
  • Unlimited access to all premium subscriber newsletters
  • Visual Stories
  • Bonus annual gift subscription
  • Priority access to all new products and features

Rs. 8,474 /year

Subscribe
Or

Questions?

What kind of subscription plans do you offer?

We have three types of subscriptions
- Premium which gives you access to either the India or the Southeast Asia edition.
- Borderless which gives you complete access to The Ken across both editions
- Echelon which gives you complete access to The Ken across both editions along with a bonus gift subscription

What do I get if I subscribe?

The Premium edition gives you access to stories in that edition along with any five subscriber-only newsletters of your choice.

The Borderless and Echelon subscription gives you complete access to The Ken across editions and unlimited access to as many newsletters as you like.

What topics do you usually write about?

We publish sharp, original and reported stories on technology, business and healthcare. Our stories are forward-looking, analytical and directional — supported by data, visualisations and infographics. We use language and narrative that is accessible to even lay readers. And we optimise for quality over quantity, every single time.

Our specialised subscriber-only newsletters are written by our expert, award-winning journalists and cover a range of topics across finance, retail, clean energy, cryptocurrency, ed-tech and many more.

How many newsletters do you have?

We are constantly adding specialised subscriber-only newsletters all the time. All of these are written by our team of award-winning journalists on a specialised topic.

You can see the list of newsletters that we publish over here.

Does a Premium subscription to your Indian edition get me access to the Southeast Asia edition? Or vice-versa?

Afraid not. Each edition is separate with its own subscription plan. The India edition publishes stories focused on India. The Southeast Asia edition is focused on Southeast Asia. We may occasionally cross-publish stories from one edition to the other.

We recommend the Borderless or the Echelon Plan which will give you access to stories across both editions.

Do you have a mobile app?

Yes! We have a top-rated mobile app on both iOS and Android which allows you to read on-the-go and has some amazing features like the ability to bookmark stories, save on your device, dark mode, and much more. It’s really the best way to read The Ken.

Is there a free trial?

You can sign up for a free account to experience The Ken and understand our products better. We’ll send you some free stories and newsletters occasionally, and you can access our archive of previously published free stories. You can stay on the free account as long as you’d like.

The vast majority of our stories, articles and newsletters can be accessed only by a paid subscription.

Do you offer any discounts?

Sorry, no. Our journalism is funded completely by our subscribers. We believe that quality journalism comes at a price, and readers trust and pay us so that we can remain independent.

Do you offer refunds?

No. We allow you to sample our journalism for free before signing up, and after you do, we stand by its quality. But we do not offer refunds.

I am facing some trouble purchasing a subscription. What can I do?

Just write to us at [email protected] with details. We’ll help you out.

I have a few more questions. How can I reach out to you?

Sure. Just email us at [email protected] or follow us on Twitter.